Histamine Toxicity Market Players:
- Johnson and Johnson company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Mylan Laboratories Ltd
- Neogen Corporation
- Pfizer Inc
- Travere Therapeutics, Inc.
- Alembic pharmaceuticals
- Intas Pharmaceuticals Ltd
- Sanofi Aventis Ltd
- Cipla Limited
- Actavis Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of histamine toxicity is estimated at USD 461.18 million.
The global histamine toxicity market size was around USD 440.18 million in 2025 and is likely to expand at a CAGR of more than 5.3%, surpassing USD 737.76 million revenue by 2035.
North America is anticipated to capture a 33% revenue share by 2035, driven by high seafood consumption and growing awareness of histamine intolerance.
Key players in the market include Travere Therapeutics, Inc., Alembic pharmaceuticals, Intas Pharmaceuticals Ltd, Sanofi Aventis Ltd, Cipla Limited, Actavis Inc.
